clomipramine has been researched along with Trichotillomania in 35 studies
Clomipramine: A tricyclic antidepressant similar to IMIPRAMINE that selectively inhibits the uptake of serotonin in the brain. It is readily absorbed from the gastrointestinal tract and demethylated in the liver to form its primary active metabolite, desmethylclomipramine.
clomipramine : A dibenzoazepine that is 10,11-dihydro-5H-dibenzo[b,f]azepine which is substituted by chlorine at position 3 and in which the hydrogen attached to the nitrogen is replaced by a 3-(dimethylamino)propyl group. One of the more sedating tricyclic antidepressants, it is used as the hydrochloride salt for the treatment of depression as well as obsessive-compulsive disorder and phobias.
Trichotillomania: Compulsion to pull out one's hair.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The major treatments reported to be effective in the treatment of trichotillomania are cognitive-behavioral therapy (CBT) with habit reversal and serotonin-norepinephrine reuptake inhibitors such as clomipramine." | 9.09 | A placebo-controlled trial of cognitive-behavioral therapy and clomipramine in trichotillomania. ( Eccard, MB; Knight, BT; Marsteller, FA; Ninan, PT; Rothbaum, BO, 2000) |
| "Four consecutive patients treated for trichotillomania (hair pulling) with clomipramine reported initially dramatic reductions in symptoms." | 7.68 | Clomipramine treatment of trichotillomania: a follow-up report on four cases. ( Bronson, SS; Flynn, TM; Ibe, IO; Kitchen, AD; Krojanker, DN; Pollard, CA, 1991) |
| "Treatment with clomipramine resulted in significantly greater improvement in symptoms than desipramine, as indicated by physicians' ratings of the women's clinical progress on a scale in which lower scores indicate improvement (mean [+/- SD] scores: at base line, 10." | 6.66 | A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling) ( Cheslow, DL; Goldberger, EL; Lenane, MC; Leonard, HL; Rapoport, JL; Swedo, SE, 1989) |
| "Twenty-five adult subjects with severe morbid onychophagia (nail biting) and no history of obsessive-compulsive disorder were enrolled in a 10-week double-blind cross-over trial of clomipramine hydrochloride and desipramine hydrochloride." | 5.07 | A double-blind comparison of clomipramine and desipramine treatment of severe onychophagia (nail biting). ( Lenane, MC; Leonard, HL; Rapoport, JL; Rettew, DC; Swedo, SE, 1991) |
| "There is preliminary evidence that clomipramine, olanzapine, and N-acetylcysteine may be effective in cases of trichotillomania, however, given the paucity of controlled studies with large sample sizes, decisions regarding the use of drugs should be made on a case-by-case basis taking into account the severity of trichotillomania and the nature of psychiatric comorbidity." | 5.05 | Pharmacotherapy for trichotillomania in adults. ( Baczynski, C; Sharma, V, 2020) |
| "Positron emission tomography and 18-F-fluorodeoxyglucose were used to study resting cerebral glucose metabolism in 10 adult women with trichotillomania and 20 age-matched female controls." | 3.68 | Regional cerebral glucose metabolism of women with trichotillomania. ( Grady, CL; Leonard, HL; Rapoport, JL; Rapoport, SI; Schapiro, MB; Swedo, SE, 1991) |
| "Four consecutive patients treated for trichotillomania (hair pulling) with clomipramine reported initially dramatic reductions in symptoms." | 3.68 | Clomipramine treatment of trichotillomania: a follow-up report on four cases. ( Bronson, SS; Flynn, TM; Ibe, IO; Kitchen, AD; Krojanker, DN; Pollard, CA, 1991) |
| "Trichotillomania is a neglected neuropsychiatric disorder that only recently has received research attention." | 2.67 | Trichotillomania. An obsessive compulsive spectrum disorder? ( Leonard, HL; Swedo, SE, 1992) |
| "Treatment with clomipramine resulted in significantly greater improvement in symptoms than desipramine, as indicated by physicians' ratings of the women's clinical progress on a scale in which lower scores indicate improvement (mean [+/- SD] scores: at base line, 10." | 2.66 | A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling) ( Cheslow, DL; Goldberger, EL; Lenane, MC; Leonard, HL; Rapoport, JL; Swedo, SE, 1989) |
| "Clomipramine was more efficacious than placebo, while there was no evidence to demonstrate that SSRI are more efficacious than placebo in the treatment of trichotillomania." | 2.44 | Systematic review: pharmacological and behavioral treatment for trichotillomania. ( Bloch, MH; Coric, V; Dombrowski, P; Kelmendi, B; Landeros-Weisenberger, A; Leckman, JF; Nudel, J; Pittenger, C; Wegner, R, 2007) |
| "Trichotillomania is a neglected psychiatric disorder with dermatologic expression that has only recently received research attention." | 2.41 | Trichotillomania. ( Hautmann, G; Hercogova, J; Lotti, T, 2002) |
| "Trichotillomania is a relatively understudied psychiatric disorder." | 1.46 | Pulling your hair out in geriatric psychiatry: a case report. ( Bartley, MM; Grant, JE; Lapid, MI, 2017) |
| "Trichotillomania is a chronic illness that may be difficult to treat." | 1.29 | Clinical profile, comorbidity, and treatment history in 123 hair pullers: a survey study. ( Aronowitz, B; Cohen, LJ; Hollander, E; Rosen, J; Simeon, D; Spadaccini, E; Stein, DJ, 1995) |
| "The current study describes successful treatment of trichotillomania in a young autistic girl, using combined clomipramine and behavioral therapy." | 1.29 | Comprehensive management of trichotillomania in a young autistic girl. ( Eastman, LE; Holttum, JR; Lubetsky, MJ, 1994) |
| "Trichotillomania is characterized by an inability to resist urges to pull out hair." | 1.28 | Behavioral aspects of trichotillomania. ( Tynes, LL; Winstead, DK, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.86) | 18.7374 |
| 1990's | 20 (57.14) | 18.2507 |
| 2000's | 7 (20.00) | 29.6817 |
| 2010's | 4 (11.43) | 24.3611 |
| 2020's | 3 (8.57) | 2.80 |
| Authors | Studies |
|---|---|
| Hoffman, J | 1 |
| Williams, T | 1 |
| Rothbart, R | 2 |
| Ipser, JC | 2 |
| Fineberg, N | 2 |
| Chamberlain, SR | 2 |
| Stein, DJ | 5 |
| Farhat, LC | 1 |
| Olfson, E | 1 |
| Nasir, M | 1 |
| Levine, JLS | 1 |
| Li, F | 1 |
| Miguel, EC | 1 |
| Bloch, MH | 2 |
| Baczynski, C | 1 |
| Sharma, V | 2 |
| Amos, T | 1 |
| Siegfried, N | 1 |
| McGuire, JF | 1 |
| Ung, D | 1 |
| Selles, RR | 1 |
| Rahman, O | 1 |
| Lewin, AB | 1 |
| Murphy, TK | 1 |
| Storch, EA | 1 |
| Landuyt, G | 1 |
| Dierckx, B | 1 |
| de Nijs, PF | 1 |
| Dieleman, GC | 1 |
| Bartley, MM | 1 |
| Lapid, MI | 1 |
| Grant, JE | 1 |
| Kordon, A | 1 |
| Broocks, A | 1 |
| Hohagen, F | 1 |
| Landeros-Weisenberger, A | 1 |
| Dombrowski, P | 1 |
| Kelmendi, B | 1 |
| Wegner, R | 1 |
| Nudel, J | 1 |
| Pittenger, C | 1 |
| Leckman, JF | 1 |
| Coric, V | 1 |
| Cohen, LJ | 1 |
| Simeon, D | 1 |
| Spadaccini, E | 1 |
| Rosen, J | 1 |
| Aronowitz, B | 1 |
| Hollander, E | 2 |
| Holttum, JR | 1 |
| Lubetsky, MJ | 1 |
| Eastman, LE | 1 |
| Mazmanian, D | 1 |
| Gupta, S | 1 |
| Freimer, M | 1 |
| Swedo, SE | 5 |
| Lenane, MC | 3 |
| Leonard, HL | 5 |
| Iancu, I | 1 |
| Weizman, A | 1 |
| Kindler, S | 1 |
| Sasson, Y | 1 |
| Zohar, J | 1 |
| Bouwer, C | 1 |
| Niehaus, DJ | 1 |
| Salama, SA | 1 |
| Salama, AA | 1 |
| Ninan, PT | 1 |
| Rothbaum, BO | 1 |
| Marsteller, FA | 1 |
| Knight, BT | 1 |
| Eccard, MB | 1 |
| Takei, A | 1 |
| Walsh, KH | 1 |
| McDougle, CJ | 1 |
| Boughn, S | 1 |
| Holdom, JA | 1 |
| Hautmann, G | 1 |
| Hercogova, J | 1 |
| Lotti, T | 1 |
| Black, DW | 1 |
| Blum, N | 1 |
| Tynes, LL | 1 |
| Winstead, DK | 1 |
| Wilens, TE | 1 |
| Steingard, R | 1 |
| Biederman, J | 1 |
| Graae, F | 1 |
| Gitow, A | 1 |
| Piacentini, J | 1 |
| Jaffer, M | 1 |
| Liebowitz, M | 1 |
| Friedman, EH | 1 |
| Rettew, DC | 1 |
| Rapoport, JL | 3 |
| Schapiro, MB | 1 |
| Rapoport, SI | 1 |
| Grady, CL | 1 |
| Naylor, MW | 1 |
| Grossman, M | 1 |
| Pollard, CA | 1 |
| Ibe, IO | 1 |
| Krojanker, DN | 1 |
| Kitchen, AD | 1 |
| Bronson, SS | 1 |
| Flynn, TM | 1 |
| Kerbeshian, J | 1 |
| Burd, L | 1 |
| Goldberger, EL | 1 |
| Cheslow, DL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| How do Glutathione Levels Affect Compulsivity? A Double-blind, Placebo-controlled Study[NCT02794389] | 23 participants (Actual) | Interventional | 2016-03-31 | Completed | |||
| A Double-Blind, Placebo-Controlled Study of Inositol in Trichotillomania[NCT01875445] | Phase 2 | 38 participants (Actual) | Interventional | 2013-05-31 | Completed | ||
| Sertraline and Habit Reversal in the Treatment of Patients With Trichotillomania[NCT00118014] | Phase 4 | 75 participants (Actual) | Interventional | 2000-01-31 | Completed | ||
| A Phase 2, Double Blind, Placebo-Controlled Study to Explore the Safety, Tolerability, and Activity of SXC-2023 in Adults With Moderate to Severe Trichotillomania (TTM) When Dosed for 6 Weeks[NCT03797521] | Phase 2 | 128 participants (Actual) | Interventional | 2018-12-19 | Completed | ||
| A 12-Week, Double-Blind Trial of Olanzapine and Placebo in the Treatment of Trichotillomania[NCT00182507] | Phase 4 | 34 participants | Interventional | 2000-06-30 | Completed | ||
| A Double-Blind, Placebo Controlled Study of Aripiprazole in Body Focused Repetitive Behaviors[NCT05545891] | Phase 2 | 100 participants (Anticipated) | Interventional | 2023-12-31 | Not yet recruiting | ||
| Double-Blind, Placebo-Controlled Trial of N-acetylcysteine for the Treatment of Pediatric Trichotillomania[NCT00993265] | Phase 2 | 39 participants (Actual) | Interventional | 2009-10-31 | Completed | ||
| A Double-Blind, Placebo-Controlled Study of N-Acetyl Cysteine in Trichotillomania[NCT00354770] | Phase 2 | 50 participants (Actual) | Interventional | 2006-07-31 | Completed | ||
| A Double-blind, Placebo-controlled Study of Naltrexone in Trichotillomania[NCT00775229] | Phase 2 | 51 participants (Actual) | Interventional | 2008-08-31 | Completed | ||
| A Double-Blind, Placebo-Controlled Study of Dronabinol in Trichotillomania and Other Body Focused Repetitive Behaviors[NCT03530800] | Phase 2/Phase 3 | 50 participants (Actual) | Interventional | 2018-10-01 | Completed | ||
| Single-Group Crossover Trial Comparing Behavioral Treatment to Memantine in Body Focused Repetitive Behaviors[NCT05796752] | Phase 2/Phase 3 | 28 participants (Anticipated) | Interventional | 2023-06-01 | Not yet recruiting | ||
| A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Titration Study to Assess the Safety, Tolerability, and Efficacy of Valbenazine for the Treatment of Trichotillomania in Adults[NCT05207085] | Phase 2 | 20 participants (Anticipated) | Interventional | 2023-10-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The entire study for an individual subject will last 10 weeks. Every 2 weeks the subject will take the MGH Hairpulling Scale for the duration of the 10 weeks, baseline and final visits will be use for general final outcome assessment. The scale itself asses severity of hair pulling. (NCT01875445)
Timeframe: Once every two weeks for the 10 weeks of the study
| Intervention | units on a scale (Mean) |
|---|---|
| Placebo | 14.5 |
| Inositol | 13.2 |
The entire study for an individual subject will last 10 weeks. Every 2 weeks the subject will take the NIMH-TSS for the duration of the 10 weeks, but only baseline and final values will be used for general final outcome assessment. The scale itself asses severity of hair pulling. (NCT01875445)
Timeframe: Once every two weeks for the 10 weeks of the study
| Intervention | units on a scale (Mean) |
|---|---|
| Placebo | 8.4 |
| Inositol | 8.4 |
The Massachusetts General Hospital - Hairpulling Scale (MGH-HPS) is a 7-question scale that measures the severity of hair pulling. The scale ranges from 0-28. The higher the score, the more severe the hairpulling. (NCT00993265)
Timeframe: Week 12
| Intervention | units on a scale (Mean) |
|---|---|
| N-acetylcysteine (NAC) | 10.9 |
| Placebo | 7.8 |
The Massachusetts General Hospital - Hairpulling Scale (MGH-HPS) is a 7-question scale that measures the severity of hair pulling. The scale ranges from 0-28. The higher the score, the more severe the hairpulling. (NCT00993265)
Timeframe: Week 12
| Intervention | units on a scale (Mean) |
|---|---|
| N-acetylcysteine (NAC) | 10.70 |
| Placebo | 13.53 |
The Multidimensional Anxiety Scale for Children (MASC) assesses major dimensions of anxiety in children. The MASC contains 39 items rated on a scale of 0-3. Scores range from 0-117. The higher the score, the greater the anxiety. (NCT00993265)
Timeframe: Week 12
| Intervention | units on a scale (Mean) |
|---|---|
| N-acetylcysteine (NAC) | 48.4 |
| Placebo | 49.8 |
The National Institute of Mental Health - Trichotillomania Severity Scale (NIMH-TSS) assesses severity of hair pulling. The NIMH-TSS is a 6 item assessment, with total scores ranging from 0-20. Higher scores indicate greater severity/impairment. (NCT00993265)
Timeframe: Week 12
| Intervention | units on a scale (Mean) |
|---|---|
| N-acetylcysteine (NAC) | 9.56 |
| Placebo | 10.89 |
The Trichotillomania Scale for Children (TSC) - Child Version assesses hair pulling severity, distress, and impairment in children. The scale is split into two sections (severity and distress/impairment), with 12 questions (5 severity and 7 distress/impairment). The severity score is summed from questions 1-5 and divided by 5. The distress/impairment score is summed from questions 6-12 and divided by 7. The total score is calculated by summing the severity score and the distress/impairment score. Scores range from 0-4. Higher total scores indicate greater severity/distress/impairment. (NCT00993265)
Timeframe: Week 12
| Intervention | units on a scale (Mean) |
|---|---|
| N-acetylcysteine (NAC) | 2.00 |
| Placebo | 2.08 |
The Trichotillomania Scale for Children (TSC) - Parent Version assesses hair pulling severity, distress, and impairment in children. The scale is split into two sections (severity and distress/impairment), with 12 questions (5 severity and 7 distress/impairment). The severity score is summed from questions 1-5 and divided by 5. The distress/impairment score is summed from questions 6-12 and divided by 7. The total score is calculated by summing the severity score and the distress/impairment score. Scores range from 0-4. Higher total scores indicate greater severity/distress/impairment. (NCT00993265)
Timeframe: Week 12
| Intervention | units on a scale (Mean) |
|---|---|
| N-acetylcysteine (NAC) | 1.83 |
| Placebo | 1.88 |
"The Milwaukee Inventory for Styles of Trichotillomania (MIST) - Child Version assesses focused pulling, hair pulling that occurs intentionally to relieve tension or distress, and automatic pulling, hair pulling that occurs outside of the child's attention. This scale contains 25 questions, 21 questions in the focused pulling subscale and 4 questions in the automatic pulling subscale. The scores range from 0-36 on the automatic pulling subscale and 0-189 on the focused pulling subscale. Higher scores on the subscales indicate more of the hair pulling is of that style." (NCT00993265)
Timeframe: Week 12
| Intervention | units on a scale (Mean) | |
|---|---|---|
| "Week 12 MIST-C Automatic Subscale" | "Week 12 MIST-C Focused Subscale" | |
| N-acetylcysteine (NAC) | 13.24 | 90.8 |
| Placebo | 13.16 | 79.6 |
There is no minimum or maximum score to quantify 'good' or 'poor' improvement based on this scale. The total score can range from 0-28 with zero being no problems to 28 being the most severe score one can receive.A total of 6 assessments were made, however only the final score (the score at the final visit after 12 weeks) was reported here to show the final outcome measure that was used in the final report of possible improvement and what was reported for final publication of data. (NCT00354770)
Timeframe: Baseline and final visit after 12 weeks
| Intervention | units on a scale (Mean) | |
|---|---|---|
| MGH-HPS Baseline | MGH-HPS Final Visit After 12 Weeks | |
| N-Acetyl Cysteine | 17.6 | 10.4 |
| Placebo | 16.7 | 16.0 |
Participants were administered a general test of liver functioning to asses safety over the course of the study. Data represent the percentage of participates with Liver Function Test values falling outside of the range considered safe/typical for liver functioning at any of the assessed time points. It was performed at baseline and at each visit where dosage of the medication is >50mg/day (week 2-week 8). (NCT00775229)
Timeframe: Week 8 (last visit)
| Intervention | percentage of individuals with LFT chang (Number) |
|---|---|
| Naltrexone | 0 |
| Placebo | 0 |
Ranges from 0-28 with 28 being the most severe. The lower the total score, the lower the severity level. This scale is given and measured once every 2 weeks for a total of 8 weeks. The final total score is reported here. (NCT00775229)
Timeframe: This is the final score, measured at week 8 (final visit).
| Intervention | units on a scale (Mean) |
|---|---|
| Naltrexone | 12.21 |
| Placebo | 13.35 |
Ranges from 0-20 with 20 being the most severe. The lower the total score, the lower the severity level. This scale is given and measured once every 2 weeks for a total of 8 weeks. The final total score is reported here. (NCT00775229)
Timeframe: This is the final score, measured at week 8 (final visit).
| Intervention | units on a scale (Mean) |
|---|---|
| Naltrexone | 7.94 |
| Placebo | 8.73 |
The entire study lasts 10 weeks. Every two weeks subjects will take the NIMH-TSS. The change in scores from baseline to after 10 weeks will be assessed. The scale itself assesses severity of trichotillomania symptoms. The NIMH-TSS score ranges from 0 to 20, with 0 being no symptoms and 20 being the most severe. (NCT03530800)
Timeframe: Assessed every two weeks up to 10 weeks, baseline data reported
| Intervention | score on a scale (Mean) |
|---|---|
| Dronabinol | 12.38 |
| Placebo | 10.63 |
The entire study lasts 10 weeks. Every two weeks subjects will take the SP-SAS. The change in scores from baseline to after 10 weeks will be assessed. The scale itself assesses severity of skin-picking symptoms. The SP-SAS score ranges from 0 to 48, with 0 being no symptoms and 48 being the most severe. (NCT03530800)
Timeframe: Assessed every two weeks up to 10 weeks, baseline reported
| Intervention | score on a scale (Mean) |
|---|---|
| Dronabinol | 24.44 |
| Placebo | 28.5 |
10 reviews available for clomipramine and Trichotillomania
| Article | Year |
|---|---|
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacotherapy for trichotillomania.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Humans; Selective | 2021 |
Pharmacological and behavioral treatment for trichotillomania: An updated systematic review with meta-analysis.
Topics: Acetylcysteine; Behavior Therapy; Clomipramine; Humans; Selective Serotonin Reuptake Inhibitors; Tri | 2020 |
Pharmacotherapy for trichotillomania in adults.
Topics: Acetylcysteine; Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clinical Trials as To | 2020 |
Pharmacotherapy for trichotillomania.
Topics: Acetylcysteine; Adult; Benzodiazepines; Clomipramine; Humans; Naltrexone; Olanzapine; Randomized Con | 2013 |
Treating trichotillomania: a meta-analysis of treatment effects and moderators for behavior therapy and serotonin reuptake inhibitors.
Topics: Adolescent; Adult; Analysis of Variance; Behavior Therapy; Clomipramine; Female; Humans; Male; Rando | 2014 |
[Treatment options for paediatric trichotillomania].
Topics: Benzodiazepines; Child; Clomipramine; Cognitive Behavioral Therapy; Comorbidity; Female; Humans; Mal | 2016 |
[Obsessive-compulsive disorders in general practice. How the obsessive-compulsive neurotic is revealed by skin and hair].
Topics: Adolescent; Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Age | 2003 |
Systematic review: pharmacological and behavioral treatment for trichotillomania.
Topics: Antidepressive Agents, Tricyclic; Behavior Therapy; Clomipramine; Double-Blind Method; Humans; Rando | 2007 |
Systematic review: pharmacological and behavioral treatment for trichotillomania.
Topics: Antidepressive Agents, Tricyclic; Behavior Therapy; Clomipramine; Double-Blind Method; Humans; Rando | 2007 |
Systematic review: pharmacological and behavioral treatment for trichotillomania.
Topics: Antidepressive Agents, Tricyclic; Behavior Therapy; Clomipramine; Double-Blind Method; Humans; Rando | 2007 |
Systematic review: pharmacological and behavioral treatment for trichotillomania.
Topics: Antidepressive Agents, Tricyclic; Behavior Therapy; Clomipramine; Double-Blind Method; Humans; Rando | 2007 |
Systematic review: pharmacological and behavioral treatment for trichotillomania.
Topics: Antidepressive Agents, Tricyclic; Behavior Therapy; Clomipramine; Double-Blind Method; Humans; Rando | 2007 |
Systematic review: pharmacological and behavioral treatment for trichotillomania.
Topics: Antidepressive Agents, Tricyclic; Behavior Therapy; Clomipramine; Double-Blind Method; Humans; Rando | 2007 |
Systematic review: pharmacological and behavioral treatment for trichotillomania.
Topics: Antidepressive Agents, Tricyclic; Behavior Therapy; Clomipramine; Double-Blind Method; Humans; Rando | 2007 |
Systematic review: pharmacological and behavioral treatment for trichotillomania.
Topics: Antidepressive Agents, Tricyclic; Behavior Therapy; Clomipramine; Double-Blind Method; Humans; Rando | 2007 |
Systematic review: pharmacological and behavioral treatment for trichotillomania.
Topics: Antidepressive Agents, Tricyclic; Behavior Therapy; Clomipramine; Double-Blind Method; Humans; Rando | 2007 |
Trichotillomania. Presentation, etiology, diagnosis and therapy.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Biopsy; Child; Child, Preschool; Clomipramine; Female; | 2001 |
Trichotillomania.
Topics: Behavior Therapy; Clomipramine; Humans; Psychotherapy; Referral and Consultation; Selective Serotoni | 2002 |
7 trials available for clomipramine and Trichotillomania
| Article | Year |
|---|---|
Long-term treatment of trichotillomania (hair pulling)
Topics: Behavior Therapy; Clomipramine; Combined Modality Therapy; Double-Blind Method; Follow-Up Studies; H | 1993 |
Serotonergic drugs in trichotillomania: treatment results in 12 patients.
Topics: Adolescent; Adult; Age of Onset; Clomipramine; Female; Fluoxetine; Fluvoxamine; Humans; Male; Recurr | 1996 |
A placebo-controlled trial of cognitive-behavioral therapy and clomipramine in trichotillomania.
Topics: Adult; Clomipramine; Cognitive Behavioral Therapy; Double-Blind Method; Female; Humans; Male; Middle | 2000 |
Trichotillomania. An obsessive compulsive spectrum disorder?
Topics: Adolescent; Adult; Child; Child, Preschool; Clomipramine; Combined Modality Therapy; Desipramine; Do | 1992 |
Low-dose pimozide augmentation of serotonin reuptake blockers in the treatment of trichotillomania.
Topics: Adult; Clomipramine; Comorbidity; Dopamine; Drug Therapy, Combination; Female; Fluoxetine; Humans; M | 1992 |
A double-blind comparison of clomipramine and desipramine treatment of severe onychophagia (nail biting).
Topics: Adult; Ambulatory Care; Clomipramine; Desipramine; Dose-Response Relationship, Drug; Double-Blind Me | 1991 |
A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling)
Topics: Adolescent; Adult; Clomipramine; Desipramine; Double-Blind Method; Female; Humans; Obsessive-Compuls | 1989 |
A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling)
Topics: Adolescent; Adult; Clomipramine; Desipramine; Double-Blind Method; Female; Humans; Obsessive-Compuls | 1989 |
A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling)
Topics: Adolescent; Adult; Clomipramine; Desipramine; Double-Blind Method; Female; Humans; Obsessive-Compuls | 1989 |
A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling)
Topics: Adolescent; Adult; Clomipramine; Desipramine; Double-Blind Method; Female; Humans; Obsessive-Compuls | 1989 |
A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling)
Topics: Adolescent; Adult; Clomipramine; Desipramine; Double-Blind Method; Female; Humans; Obsessive-Compuls | 1989 |
A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling)
Topics: Adolescent; Adult; Clomipramine; Desipramine; Double-Blind Method; Female; Humans; Obsessive-Compuls | 1989 |
A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling)
Topics: Adolescent; Adult; Clomipramine; Desipramine; Double-Blind Method; Female; Humans; Obsessive-Compuls | 1989 |
A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling)
Topics: Adolescent; Adult; Clomipramine; Desipramine; Double-Blind Method; Female; Humans; Obsessive-Compuls | 1989 |
A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling)
Topics: Adolescent; Adult; Clomipramine; Desipramine; Double-Blind Method; Female; Humans; Obsessive-Compuls | 1989 |
18 other studies available for clomipramine and Trichotillomania
| Article | Year |
|---|---|
Pulling your hair out in geriatric psychiatry: a case report.
Topics: Aged; Behavior Therapy; Clomipramine; Female; Geriatric Psychiatry; Habits; Humans; Psychiatric Stat | 2017 |
Clinical profile, comorbidity, and treatment history in 123 hair pullers: a survey study.
Topics: Adolescent; Adult; Age Distribution; Age of Onset; Behavior Therapy; Child; Child, Preschool; Clomip | 1995 |
Comprehensive management of trichotillomania in a young autistic girl.
Topics: Autistic Disorder; Behavior Therapy; Child, Preschool; Clomipramine; Combined Modality Therapy; Fema | 1994 |
A case of chronic haircutting.
Topics: Body Image; Clomipramine; Delusions; Diagnosis, Differential; Drug Therapy, Combination; Female; Hai | 1993 |
Trichotillomania, clomipramine, topical steroids.
Topics: Adolescent; Clomipramine; Female; Fluocinolone Acetonide; Humans; Trichotillomania | 1993 |
Stereotypic movement disorder.
Topics: Adult; Antipsychotic Agents; Clomipramine; Desipramine; Drug Therapy, Combination; Female; Humans; M | 1997 |
New behavioral approach to trichotillomania.
Topics: Adolescent; Adult; Behavior Therapy; Child; Clomipramine; Combined Modality Therapy; Female; Fluoxet | 1999 |
A case of trichotillomania successfully treated with clomipramine.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Clomipramine; Female; Humans; Trichotillomania | 2000 |
Trichotillomania: women's reports of treatment efficacy.
Topics: Adaptation, Psychological; Adult; Attitude to Health; Behavior Therapy; Clomipramine; Complementary | 2002 |
Trichotillomania treated with clomipramine and a topical steroid.
Topics: Administration, Topical; Adult; Clomipramine; Female; Fluocinolone Acetonide; Humans; Pruritus; Tric | 1992 |
Behavioral aspects of trichotillomania.
Topics: Adult; Behavior Therapy; Child; Child, Preschool; Clomipramine; Female; Humans; Male; Trichotilloman | 1992 |
Clomipramine for comorbid conditions.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Clomipramine; Female; Humans; Obsessive-Compul | 1992 |
Response of obsessive-compulsive disorder and trichotillomania to serotonin reuptake blockers.
Topics: Adolescent; Clomipramine; Female; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Trichotillomani | 1992 |
Clomipramine treatment of trichotillomania.
Topics: Clomipramine; Female; Humans; Male; Sex Factors; Trichotillomania | 1991 |
Regional cerebral glucose metabolism of women with trichotillomania.
Topics: Adult; Brain; Cerebellum; Clomipramine; Deoxyglucose; Female; Fluorodeoxyglucose F18; Frontal Lobe; | 1991 |
Trichotillomania and depression.
Topics: Adolescent; Clomipramine; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans | 1991 |
Clomipramine treatment of trichotillomania: a follow-up report on four cases.
Topics: Adolescent; Adult; Clomipramine; Female; Follow-Up Studies; Humans; Recurrence; Trichotillomania | 1991 |
Familial trichotillomania.
Topics: Adult; Clomipramine; Family; Female; Fluoxetine; Humans; Trichotillomania | 1991 |